Temoporfin is a porphyrin-based photosensitizing agent utilized in photodynamic therapy for the treatment of squamous cell carcinomas of the head and neck. This drug functions by accumulating in malignant… Read more
Temoporfin is a porphyrin-based photosensitizing agent utilized in photodynamic therapy for the treatment of squamous cell carcinomas of the head and neck. This drug functions by accumulating in malignant tissues and generating cytotoxic reactive oxygen species upon exposure to specific wavelengths of light. The category includes essential reference standards for the Temoporfin active pharmaceutical ingredient, as well as its identified impurities, metabolites, and stable isotope labelled compounds. These high-quality reference materials are critical for pharmaceutical laboratories performing analytical method validation, quality control, and impurity profiling. Stable isotope labelled compounds, in particular, are frequently used as internal standards in mass spectrometry to ensure precise quantification and method accuracy. By providing reliable benchmarks, these standards support the stringent regulatory requirements for drug identity, purity, and potency throughout the development and manufacturing processes of oncology therapeutics.